XRF Scientific (XRF)

[mark100]

I dumped it a long time ago winner69. Management didn't seem up to the job. Haven't followed it since

[steve fleming]

some impressive growth here:

Revenue from continuing operations, up 61% to $20.3 million (FY10: $12.6 million);
Earnings Before Interest and Tax (EBIT), up 904% to $3.8 million (FY10: $0.4 million);
Net Profit After Tax (NPAT), up 770% to $2.6 million (FY10: $0.3 million);

Market cap just under $30m, revenues and margins are likely to continue to expand.

Nice exposure to mining (XRF manufactures equipment and chemicals, which are distributed to laboratories in
Australia and overseas and used in the preparation of samples for analysis).

Dividends reinstated as well.

[Huang Chung]

G'day Steve

Geos love their XRF machines! Sometimes I think they rely on them too much.

Almost as ubiquitous as the rock hammer these days!

[soulman]

Could XRF be a T/O target for the likes of CPB. I will have XRF on my to buy list.

They actually have CPB as one of their clients.

[macduffy]

Agree with that, soulman. I've long seen XRF as a potential target for CPB who have a track record of taking out smaller firms in their wider field of scientific testing and analysis.

I hold quite a few CPB, one of my best ASX performers of recent years. Otherwise, might have already had a nibble at XRF!

[soulman]

A decent result. Bought some for their dividends.....

I just like coy with net cash position and pay dividends with the likes of FWD, BSA, XRF, MND, GNG all in buy on weakness watchlist.

[Snoopy]

some impressive growth here:

Revenue from continuing operations, up 61% to $20.3 million (FY10: $12.6 million);
Earnings Before Interest and Tax (EBIT), up 904% to $3.8 million (FY10: $0.4 million);
Net Profit After Tax (NPAT), up 770% to $2.6 million (FY10: $0.3 million);

Market cap just under $30m, revenues and margins are likely to continue to expand.

Had a look at this because of the announced SCT joint venture for FY2013. Growth in eps terms not as impressive as you think because many new shares were issued in the Sigma Chemicals purchase and FY2010 being the year most affected by the GFC.

I calculate eps/dps figures as follows:

2008: 1.0, 0
2009: 2.1, 0.5
2010: 0.6, 0.75
2011: 2.8, 0
2012: 2.8, 1.0

Nevertheless the margins are decent ( FY2011: 14.2%, FY2012 13.8% ) with ROE quite respectable considering the company has no debt now ( FY2011: 14.8%, FY2012 13.5% ).

At 25.5c XFR is on an historic PE of 9.1. Probably about right considering some customers might be having a tougher year in FY2013.

SNOOPY

[percy]

https://stocknessmonster.com/announc....asx-6A992651/
A great presentation.
Yet another of DMX's portfolio that I followed them into.
www.dmxam.com.au

[percy]

https://stocknessmonster.com/announc...asx-6A1002762/
Another positive presentation.
Interesting noting a new machine for a new sector.Look forward to more details.
To save hiccups with their divie, I elected to take DRP.New shares were allocated a few days ago.

[Nigel]

What price did you enter at Percy? This looks like one of those stocks that flies under the radar. Has quietly improved earnings and divs over the past few years. I have a small parcel, considering increasing my stake.